 |
 |
|
|
RESÚMENES ABRIL 2005 |
Other Neuropsychiatric Disorders & General Information
(Requiere estar conectado a internet. Haga un click en la
información del journal)
Does Donepezil Treatment Slow the Progression of Hippocampal Atrophy in Patients With Alzheimer’s Disease?
Mamoru Hashimoto, Hiroaki Kazui, Keiji Matsumoto, Yoko Nakano, Minoru
Yasuda, and Etsuro Mori
Am
J Psychiatry 162:676-682, April 2005
Effect of Raloxifene on Prevention of Dementia and Cognitive Impairment in Older Women: The Multiple Outcomes of Raloxifene Evaluation (MORE) Randomized Trial
Kristine Yaffe, Kathryn Krueger, Steven R. Cummings, Terri Blackwell,
Victor W. Henderson, Somnath Sarkar, Kristine Ensrud, and Deborah Grady
Am
J Psychiatry 162:683-690, April 2005
Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors
An-Wen Chan, Douglas G Altman
Suicide Risk in Relation to Psychiatric Hospitalization. Evidence Based on
Longitudinal Registers
Ping
Qin, Merete Nordentoft
Arch Gen Psychiatry. 2005;62:427-432
The influence of psychotropic drugs on cerebral cell death: female
neurovulnerability to antipsychotics.
Bonelli, Raphael M; Hofmann, Peter; Aschoff, Andreas;
Niederwieser, Gerald; Heuberger, Clemens; Jirikowski, Gustaf; Kapfhammer,
Hans-Peter
International Clinical
Psychopharmacology. 20(3):145-149, May 2005.
Past use of selective serotonin reuptake inhibitors and the risk of
cerebrovascular events in the elderly.
Barbui, Corrado; Percudani, Mauro; Fortino, Ida; Tansella,
Michele; Petrovich, Lorenzo
International Clinical
Psychopharmacology. 20(3):169-171, May 2005.
A case for
judicious use of risperidone and olanzapine in behavioral and psychological
symptoms of dementia (BPSD)
AJIT SHAH
and GUK HEE SUH
International Psychogeriatrics (2005), 17:1:12-22
The
differentiation of mild frontotemporal dementia from Alzheimer's disease and
healthy aging by neuropsychological tests
Alexandra
J. Walker, Susanne Meares, Perminder S. Sachdev and
Henry Brodaty
International Psychogeriatrics (2005), 17:1:57-68
Double-blind,
placebo-controlled, unforced titration parallel trial of quetiapine for
dopaminergic-induced hallucinations in Parkinson's disease
Ondo WG, Tintner R, Dat
Voung K, Lai D, Ringholz G
Mov Disord. 2005 Mar 30; [Epub ahead of print]
Bupropion XL in
adults with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled
study
Timothy E. Wilens,
Barbara R. Haight, Joseph P. Horrigan, James J. Hudziak, Norman E. Rosenthal,
Daniel F. Connor, Kenneth D. Hampton, Nathalie E. Richard and Jack G. Modell
Biological Psychiatry. Volume 57, Issue 7, 15 March 2005, Pages
793-801
Drug
therapy of dementia in elderly patients. A review
Carsten Emil Olsen , Henrik
Day Poulsen , Henrik K. F. Lublin
Nordic Journal of
Psychiatry. Volume 59, Number 2 / April 2005: 71 - 77
C. Barbui,
A. Ciuna, M. Nosè, D. Levi, M. Andretta,
S. B. Patten, F. Amaddeo and M. Tansella
European Archives of Psychiatry and Clinical Neuroscience 2005; Volume 255, Number 2: 136 - 142
E. Baca–Garcia,
C. Diaz–Sastre, E. García Resa, H. Blasco, D. Braquehais
Conesa, M. A. Oquendo, J. Saiz-Ruiz and J. de Leon
European Archives of Psychiatry and Clinical Neuroscience 2005; Volume 255, Number 2: 152 - 156
Meta-analysis:
pharmacologic treatment of obesity.
Li Z, Maglione M, Tu W,
Mojica W, Arterburn D, Shugarman LR, Hilton L, Suttorp M, Solomon V, Shekelle
PG, Morton SC.
Ann Intern Med. 2005 Apr 5;142(7):532-46
Anxiogenic effects
of Sumatriptan in panic disorder: A double-blind, placebo-controlled study
Daniella Amital,
Leah Fostick, Yehuda Sasson, Seth Kindler, Howard Amital and Joseph Zohar
European Neuropsychopharmacology. Volume 15, Issue 3,
May 2005, Pages 279-282
Wallace B.
Mendelson
J Clin Psychiatry 2005;66:469-476
Marie D. Sauro and
Roger P. Greenberg
Journal of Psychosomatic Research. Volume 58, Issue 2,
February 2005, Pages 115-120
Reconsidering the
role of personality in placebo effects: Dispositional optimism, situational
expectations, and the placebo response
Andrew L. Geers,
Suzanne G. Helfer, Kristin Kosbab, Paul E. Weiland and Sarah J. Landry
Journal of Psychosomatic Research. Volume 58, Issue 2,
February 2005, Pages 121-127
DrKenneth F Schulz
and David A Grimes
The
Lancet. Volume 365, Issue 9467, 9 April 2005-15 April 2005, Pages 1348-1353
Social
Isolation, Impulsivity and Depression as Predictors of Aggression in a
Psychiatric Inpatient Population
Christopher J. Ferguson,
Patricia M. Averill, Howard Rhoades, Donna Rocha,
Nelson P. Gruber and Pushpa Gummattira
Psychiatric Quarterly 2005;
Volume 76, Number 2: 123 - 137
Olanzapine
as a possible treatment of behavioral symptoms in vascular dementia: risks of
cerebrovascular events A controlled, open-label study.
Moretti R, Torre P,
Antonello RM, Cattaruzza T, Cazzato G
J Neurol. 2005 Apr 13; [Epub ahead of print]
Josh
F. Peterson, Gilad J. Kuperman, Caroline Shek, Minalkumar Patel, Jerry Avorn,
David W. Bates
Arch Intern Med. 2005;165:802-807
Sudeep
S. Gill, Muhammad Mamdani, Gary Naglie, David L. Streiner, Susan E. Bronskill,
Alexander Kopp, Kenneth I. Shulman, Philip E. Lee, Paula A. Rochon
Arch Intern Med. 2005;165:808-813
Differential
cognitive effects of Ginkgo biloba after acute and chronic treatment in healthy
young volunteers
Sarah Elsabagh,
David E. Hartley, Osama Ali, Elizabeth M. Williamson
and Sandra E. File
Psychopharmacology 2005;
Volume 179, Number 2: 437 - 446
H.C. Deter, D.
Schellberg, W. Köpp, H.C. Friederich and W. Herzog
European
Psychiatry. Volume 20, Issue 2, March 2005, Pages 165-172
Antipsychotics
and dopamine transporter gene polymorphisms in delirium patients.
Kim JY, Jung IK, Han C, Cho
SH, Kim L, Kim SH, Lee BH, Lee HJ, Kim YK
Psychiatry Clin Neurosci. 2005 Apr;59(2):183-8
Early traumatic
life events, parental attitudes, family history, and birth risk factors in
patients with borderline personality disorder and healthy controls
Borwin Bandelow,
Joana Krause, Dirk Wedekind, Andreas Broocks, Göran Hajak and Eckart Rüther
Psychiatry Research. Volume 134, Issue 2, 15 April 2005, Pages
169-179
Christian Prueter and Christine Norra
J
Neuropsychiatry Clin Neurosci 17:20-28, February 2005
ARIF KHAN,
RUSSELL L. KOLTS, MARK H. RAPAPORT, K. RANGA RAMA KRISHNAN, AMY
E. BRODHEAD and WALTER A. BROWN
Psychological Medicine
(2005), 35:5:743-749
STEPHEN
A. WONDERLICH, ROSS D. CROSBY, THOMAS JOINER, CAROL
B. PETERSON, ANNA BARDONE-CONE, MARJORIE KLEIN, SCOTT CROW,
JAMES E. MITCHELL, DANIEL LE GRANGE, HOWARD STEIGER,
GREG KOLDEN, FRANK JOHNSON and SUZANNE VRSHEK
Psychological Medicine
(2005), 35:5:649-657
Psychopathic
personality traits: heritability and genetic overlap with internalizing and
externalizing psychopathology
DANIEL
M. BLONIGEN, BRIAN M. HICKS, ROBERT F. KRUEGER, CHRISTOPHER
J. PATRICK and WILLIAM G. IACONO
Psychological Medicine
(2005), 35:5:637-648
Reconsidering the role of personality in
placebo effects: Dispositional optimism, situational expectations, and the
placebo response
Andrew
L.Geers, Suzanne G.Helfer, Kristin Kosbab, Paul E.Weiland, Sarah J.Landry
J Psychosom Res. Volume 58;
Issue 2, Pages 121-127 (February 2005)
Luisa
Ibáñez, Xavier Vidal, Elena Ballarín, Joan-Ramon Laporte
Arch Intern Med. 2005;165:869-874
Pauline
S.Powers, Heather Simpson, and Terrance McCormick
Primary
Psychiatry.2005;12(4):39-45
David
S.Husted, and Nathan A.Shapira
Primary
Psychiatry.2005;12(4):46-51
Suicides of psychiatric hospitalized patients and their risk factors: A case control study
BAADER - MATTHEI,
Tomas, RICHTER, Paul and MUNDT, Christoph.
Rev. chil. neuro-psiquiatr., Oct. 2004, vol.42, no.4,
p.293-316
Cristina
Marta Del-Ben
Rev Psiquiatria Clinica 2005 Vol 32(1)
Efectos
adversos endocrinos de los psicofármacos
I.M.
Elenitza
W. Victor R.
Vieweg, Lisa J. Kuhnley, E. John Kuhnley, Emmanuel A. Anum, Bela Sood, Anand
Pandurangi and Joel J. Silverman